Effect of Policosanol as Monotherapy and Adjunctive to Statin Therapy

Completed · Not applicable · Has a placebo group

Conditions studied: High Cholesterol

In brief

To determine the effects of policosanol on the cholesterol profile.

Key facts

Study ID

NCT00510809

Run by

James Backes, PharmD

People needed

54

Starts

2007-07-01

Expected to finish

2010-05-01

Last updated by the study team

2015-10-08

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• LDL > 100
• Male or Non-Pregnant Female. Women must be surgically sterile or postmenopausal and not using hormone replacement therapy (HRT) or using a stable, consistent HRT dose with intentions to continue therapy throughout the course of the study
• Mentally competent to understand study rationale and protocol
• Speak and read English
• Currently receiving low to moderate dose statin therapy with plans to continue to the same dose for at least 8 weeks. Low to moderate dose statins include the following daily doses: atorvastatin ≤20 mg, fluvastatin ≤40 mg, lovastatin ≤40 mg, pravastatin ≤40 mg, rosuvastatin ≤10 mg, simvastatin ≤ 40 mg

You may not qualify if…

• LDL < 100
• Sensitivity to policosanol
• Currently taking a high-dose statin or other lipid-lowering agents (i.e. high-dose niacin formulations [>500mg/day], bile-acid sequestrants, ezetimibe, fibrates and high-dose Omega-3 fish oils [>900mg of combined EPA/DHA daily])
• Currently taking medications which have the potential to interact with policosanol (i.e. warfarin, high-dose aspirin)
• Active liver disease or ALT level 2.5 times the upper limit of normal
• Chronic disease involving hepatic, renal or coronary artery disease
• Currently experiencing "flu-like" symptoms
• Currently experiencing any form of acute physical injury
• Acute psychiatric disorders
• Immuno-compromised state
• Currently taking systemic steroidal drugs
• Currently pregnant or lactating
• Females of childbearing potential
• Dependence on alcohol or illicit drugs
• Participation in any other clinical trial within the last 30 days
• Displays s/s of acute systemic infection (oral temperature >100°F, WBC>12x10³/µL)

Where it is running

• University of Kansas Medical Center — Kansas City, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.